DOI QR코드

DOI QR Code

Characteristics and Incidence Trends for Pediatric Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center Study

  • Hong, Suk Jin (Department of Pediatrics, Daegu Catholic University School of Medicine) ;
  • Cho, Seung Man (Department of Pediatrics, Dongguk University School of Medicine) ;
  • Choe, Byung-Ho (Department of Pediatrics, School of Medicine, Kyungpook National University) ;
  • Jang, Hyo Jeong (Department of Pediatrics, Keimyung University School of Medicine) ;
  • Choi, Kwang Hae (Department of Pediatrics, Yeungnam University School of Medicine) ;
  • Kang, Ben (Department of Pediatrics, School of Medicine, Kyungpook National University) ;
  • Kim, Jung Eun (Department of Pediatrics, School of Medicine, Kyungpook National University) ;
  • Hwang, Jun Hyun (Department of Preventive Medicine, Daegu Catholic University School of Medicine)
  • Received : 2017.10.10
  • Accepted : 2018.02.27
  • Published : 2018.04.30

Abstract

Background: Inflammatory bowel disease (IBD) is a heterogeneous chronic disease of unknown etiology. Although it is an important disease that shows a rapid increase in pediatric population, there are no pediatric studies that represent a specific region in Korea. Therefore, we studied the epidemiological and phenotypic characteristics of pediatric IBD in Daegu-Kyungpook province, Korea. Methods: We included 122 children with pediatric IBD initially diagnosed at one of four university hospitals in Daegu-Kyungpook province between July 2010 and June 2016. We investigated the incidence trends, and the clinical characteristics at diagnosis were compared by Paris classification. Results: We included 122 children: 98 with Crohn's disease (CD) and 24 with ulcerative colitis (UC). The average age at diagnosis was 13.6 years for IBD. The incidence shows an increasing trend. CD showed a significant increase, whereas UC appears to be increasing slowly. In CD, there was a significant male predominance. For disease activity sites, the most common location was L3 (77.6%), indicating ileocolonic involvement as the major type. B1 (88.8%) was the most common disease behaviors type. Perianal disease was noted in 43 patients (43.9%) and weight loss in 60 (61.2%). In UC, E4 (58.4%) was the most common disease activity site, indicating pancolonic involvement as the major type. Conclusion: We found that the number of pediatric patients with IBD is increasing rapidly in Daegu-Kyungpook province in Korea. Our study also revealed that the characteristics of pediatric IBD in our province differ somewhat from those of pediatric IBD in Western countries.

Keywords

References

  1. Yang SK, Yun S, Kim JH, Park JY, Kim HY, Kim YH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008;14(4):542-9. https://doi.org/10.1002/ibd.20310
  2. Kim BJ, Song SM, Kim KM, Lee YJ, Rhee KW, Jang JY, et al. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience. Dig Dis Sci 2010;55(7):1989-95. https://doi.org/10.1007/s10620-009-0963-5
  3. Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011;17(1):423-39. https://doi.org/10.1002/ibd.21349
  4. Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17(6):1314-21. https://doi.org/10.1002/ibd.21493
  5. Song SM, Kim Y, Oh SH, Kim KM. Nutritional status and growth in Korean children with Crohn's disease: a single-center study. Gut Liver 2014;8(5):500-7. https://doi.org/10.5009/gnl13183
  6. Malmborg P, Grahnquist L, Lindholm J, Montgomery S, Hildebrand H. Increasing incidence of paediatric inflammatory bowel disease in northern Stockholm County, 2002-2007. J Pediatr Gastroenterol Nutr 2013;57(1):29-34. https://doi.org/10.1097/MPG.0b013e31828f21b4
  7. Benchimol EI, Guttmann A, Griffiths AM, Rabeneck L, Mack DR, Brill H, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 2009;58(11):1490-7. https://doi.org/10.1136/gut.2009.188383
  8. Malaty HM, Fan X, Opekun AR, Thibodeaux C, Ferry GD. Rising incidence of inflammatory bowel disease among children: a 12-year study. J Pediatr Gastroenterol Nutr 2010;50(1):27-31. https://doi.org/10.1097/MPG.0b013e3181b99baa
  9. Benchimol EI, Manuel DG, Guttmann A, Nguyen GC, Mojaverian N, Quach P, et al. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis 2014;20(10):1761-9. https://doi.org/10.1097/MIB.0000000000000103
  10. Kang B, Choe YH. Early biologic treatment in pediatric crohn's disease: catching the therapeutic window of opportunity in early disease by treat-to-target. Pediatr Gastroenterol Hepatol Nutr 2018;21(1):1-11. https://doi.org/10.5223/pghn.2018.21.1.1
  11. Lee HA, Suk JY, Choi SY, Kim ER, Kim YH, Lee CK, et al. Characteristics of pediatric inflammatory bowel disease in Korea: comparison with EUROKIDS data. Gut Liver 2015;9(6):756-60. https://doi.org/10.5009/gnl14338
  12. Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res 2016;14(2):111-9. https://doi.org/10.5217/ir.2016.14.2.111
  13. de Bie CI, Paerregaard A, Kolacek S, Ruemmele FM, Koletzko S, Fell JM, et al. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis 2013;19(2):378-85. https://doi.org/10.1002/ibd.23008
  14. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002;16(1):51-60. https://doi.org/10.1046/j.1365-2036.2002.01140.x
  15. Lakatos L, Kiss LS, David G, Pandur T, Erdelyi Z, Mester G, et al. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis 2011;17(12):2558-65. https://doi.org/10.1002/ibd.21607
  16. Lowe AM, Roy PO, B-Poulin M, Michel P, Bitton A, St-Onge L, et al. Epidemiology of Crohn's disease in Quebec, Canada. Inflamm Bowel Dis 2009;15(3):429-35. https://doi.org/10.1002/ibd.20756
  17. Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 2003;143(4):525-31. https://doi.org/10.1067/S0022-3476(03)00444-X
  18. Lee NY, Park JH. Clinical features and course of Crohn disease in children. Korean J Gastrointest Endosc 2007;34(4):193-9.
  19. Muller KE, Lakatos PL, Arato A, Kovacs JB, Varkonyi A, Szucs D, et al. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013;57(5):576-82. https://doi.org/10.1097/MPG.0b013e31829f7d8c
  20. Hope B, Shahdadpuri R, Dunne C, Broderick AM, Grant T, Hamzawi M, et al. Rapid rise in incidence of Irish paediatric inflammatory bowel disease. Arch Dis Child 2012;97(7):590-4. https://doi.org/10.1136/archdischild-2011-300651
  21. Lee YA, Chun P, Hwang EH, Mun SW, Lee YJ, Park JH. Clinical features and extraintestinal manifestations of Crohn disease in children. Pediatr Gastroenterol Hepatol Nutr 2016;19(4):236-42. https://doi.org/10.5223/pghn.2016.19.4.236
  22. Levine A, de Bie CI, Turner D, Cucchiara S, Sladek M, Murphy MS, et al. Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis 2013;19(2):370-7. https://doi.org/10.1002/ibd.23013

Cited by

  1. A contact investigation after exposure to a child with disseminated tuberculosis mimicking inflammatory bowel disease vol.61, pp.11, 2018, https://doi.org/10.3345/kjp.2018.07206
  2. Successful Transition from Pediatric to Adult Care in Inflammatory Bowel Disease: What is the Key? vol.22, pp.1, 2018, https://doi.org/10.5223/pghn.2019.22.1.28
  3. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases vol.22, pp.1, 2018, https://doi.org/10.5223/pghn.2019.22.1.50
  4. Vitamin A and inflammatory bowel diseases: from cellular studies and animal models to human disease vol.13, pp.1, 2019, https://doi.org/10.1080/17474124.2019.1543588
  5. Acute pancreatitis associated with indigo naturalis in pediatric severe Crohn’s disease vol.17, pp.1, 2019, https://doi.org/10.5217/ir.2018.00104
  6. Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key? vol.17, pp.1, 2019, https://doi.org/10.5217/ir.2018.00128
  7. Clinical aspects and treatments for pediatric inflammatory bowel diseases vol.17, pp.1, 2018, https://doi.org/10.5217/ir.2018.00139
  8. Impact of Education on School Nurses’ Knowledge of Inflammatory Bowel Disease vol.13, pp.1, 2018, https://doi.org/10.5009/gnl18139
  9. Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study vol.8, pp.4, 2018, https://doi.org/10.2196/15124
  10. Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts vol.23, pp.1, 2018, https://doi.org/10.5223/pghn.2020.23.1.49
  11. Prevention of thiopurine-induced early leukopenia in a Korean pediatric patient with Crohn's disease who turned out to possess homozygous mutations in NUDT15 R139C vol.37, pp.4, 2020, https://doi.org/10.12701/yujm.2020.00178
  12. Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis vol.36, pp.44, 2018, https://doi.org/10.3346/jkms.2021.36.e278
  13. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease vol.21, pp.None, 2018, https://doi.org/10.1186/s12887-021-02496-4
  14. Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment? vol.77, pp.5, 2018, https://doi.org/10.4166/kjg.2021.067
  15. Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management vol.36, pp.5, 2018, https://doi.org/10.3904/kjim.2021.114
  16. Anti-Saccharomyces cerevisiae Antibody in Pediatric Crohn's Disease Patients without Mucosal Healing Is a Useful Marker of Mucosal Damage vol.15, pp.5, 2021, https://doi.org/10.5009/gnl20212
  17. Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease vol.19, pp.4, 2018, https://doi.org/10.5217/ir.2020.00107
  18. Incidentally Detected Asymptomatic Perianal Abscess in an Adolescent during Crohn's Disease Diagnosis: Is Routine Pelvic Imaging Required in Korean Pediatric Patients at Diagnosis? vol.24, pp.6, 2018, https://doi.org/10.5223/pghn.2021.24.6.564